Table 1.
Parameter | Median (Q1–Q3) | Significance of the differences |
---|---|---|
Calprotectin (pg/mL) | ||
Controls | 1943.0 (1260.0–2488.0) | p < 0.001 |
Patients | 5231.0 (4159.0–8041.0) | |
ANGPTL8 (ng/mL) | ||
Controls | 11.97 (9.63–15.10) | NS |
Patients | 13.80 (10.83–14.72) | |
Oxidative damage to nucleic acids (pg/mL) | ||
Controls | 1730.0 (981.0–2643.4) | p < 0.001 |
Patients | 3269.3 (2004.4–4505.9) |
Legend: Q1: first quartile; Q3: third quartile.